ICU Medical, Inc.
ICUI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $537 | $549 | $605 | $630 |
| % Growth | -2.2% | -9.2% | -4% | – |
| Cost of Goods Sold | $336 | $341 | $395 | $403 |
| Gross Profit | $201 | $208 | $210 | $227 |
| % Margin | 37.4% | 37.9% | 34.7% | 36.1% |
| R&D Expenses | $21 | $22 | $23 | $22 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $153 | $159 | $157 | $159 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $13 | $16 | $17 | $8 |
| Operating Expenses | $187 | $197 | $197 | $190 |
| Operating Income | $14 | $11 | $13 | $38 |
| % Margin | 2.6% | 1.9% | 2.1% | 6% |
| Other Income/Exp. Net | -$18 | $26 | -$24 | -$29 |
| Pre-Tax Income | -$4 | $37 | -$11 | $8 |
| Tax Expense | -$1 | $1 | $5 | $32 |
| Net Income | -$3 | $35 | -$15 | -$24 |
| % Margin | -0.6% | 6.4% | -2.6% | -3.8% |
| EPS | -0.14 | 1.43 | -0.63 | -0.97 |
| % Growth | -109.8% | 327% | 35.1% | – |
| EPS Diluted | -0.14 | 1.43 | -0.63 | -0.97 |
| Weighted Avg Shares Out | 25 | 25 | 25 | 24 |
| Weighted Avg Shares Out Dil | 25 | 25 | 25 | 24 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $3 | $3 | $3 |
| Interest Expense | $20 | $23 | $29 | $26 |
| Depreciation & Amortization | $51 | $50 | $49 | $53 |
| EBITDA | $67 | $106 | $64 | $87 |
| % Margin | 12.4% | 19.4% | 10.6% | 13.9% |